Introduction
Since the outbreaks of cholera in 1992-1993, Yibrio cholerae 0139 Bengal has become established as a causative agent of endemic cholera in the Indian subcontinent. Genetic studies indicated that r cholerae 0139 is probably a mutant of r cholerae 0 1 El Tor, and that it might have arisen by substitution of rfb genes that encode the lipopolysaccharide (LPS) antigen in r cholerae 0 1 by genes that encode the LPS antigen and the capsular antigen of K cholerae 0139 [l] . The organism that would potentially donate rfb genes for surface polysaccharide synthesis in V cholerae 0 139 has not been identified. T cholerae 0139 also crossreacts with a number of bacteria, including l T cholerae serogroups 022 and 0155 [2] , and Aeromonas trota [3] . In addition, as the core antigen is common to all l! cholerae serogroups, l! cholerae 0139 also shares this antigen with other ? ! cholerae serogroups [2] . Therefore, for production of specific diagnostic polyclonal antiserum to cholerae 0139, the antiserum must be absorbed with a rough strain of I ? cholerae and with J ! cholerae 022 and 0155 [2] . A rapid test based on specific monoclonal antibodies (MAbs) to i ? cholerae 0139 has been developed that detects the bacterium directly from the samples [4] . The objectives of a search for bacteria that cross-react with r cholerae 0139 are three-fold: to identi@ the bacterium that would have donated the rfb genes for 0139 antigen, to continually ensure the specificity of monoclonal and polyclonal sera to l! cholerae 0139 for diagnosis, and to characterise cross-reacting bacteria for general microbiological interest. The continuing search for cross-reacting bacteria identified a water isolate of V mimicus that agglutinated with I ? cholerae 0139
antiserum. This isolate was characterised with respect to its antigenic and virulence properties.
Materials and methods

Bacterial strains
One hundred r mimicus strains isolated from diar- 
Tube agglutination test
The tube agglutination test was performed as described previously. Doubling dilutions of antisera were tested from a starting dilution of 1 in 20. Agglutination was scored on a 0 to 4+ scale, and the endpoint titre was defined as the highest dilution of antiserum yielding a 2+ agglutination of cells [3] .
Agglutinin-absorption test
After incubation of antigen-antibody mixture, the supernate was filter-sterilised. Antisera were absorbed either with a single culture or multiple cultures as required [3] .
Serogrouping
The cross-reacting K mimicus strain was subjected to 0 serogrouping with antisera to the 155 serogroups of K cholerae previously recognised [2] and to 38 other serogroups (serogroups 0 156-0 193) recognised subsequently (unpublished data). K cholerae and ?? mimicus have a common serogrouping scheme.
Studies with LPS antigens
LPS was extracted by the hot phenol-water extraction method, separated on SDS-polyacrylamide 13.5% gels and visualised by silver staining. For immunoblotting, the separated LPS was probed with rabbit polyclonal antiserum to the relevant bacteria, and then with alkaline phosphatase-conjugated swine anti-rabbit IgG ~31.
PCR assay for I ? cholerae 0139 antigen
The cross-reacting ?? mimicus was tested in a PCR assay with primers specific for the 0-antigen of I ?
cholerae 0139 as described previously [7] .
Enterotoxin production
Culture filtrate was tested in mouse Y1 adrenal tumour cells for cholera toxin-like enterotoxin and in the suckling mouse assay for heat-stable enterotoxin [3] . The criterion for a positive test in the Y1 cell assay was rounding of >50% of the cell monolayer, and that for the suckling mouse assay was a ratio of B0.085 for intestinal body weight to remaining body weight from five mice per test [3] .
The cross-reacting K mimicus strain was also tested in a PCR assay for cholera toxin gene (ctx) with two primers corresponding to the ctx operon of K cholerae 0 1 as described previously [8] .
Passive protection in infant mouse cholera model
To study the protective efficacy of polyclonal antiserum to the cross-reacting K mimicus, 0.1 ml of a 1 in 10 diluted antiserum in physiological saline was mixed with a 100 LD50 dose of a clinical isolate of K cholerae 0139 (strain AI-1852) and injected into a group of 4-day-old mice. Mortality was observed for up to 48 h [9].
Results and discussion
Of 200 K mimicus strains tested, only one strain, isolated from pond water, agglutinated with K cholerae 0139 polyclonal antiserum (absorbed only with K cholerae CA385) in a slide agglutination test. However, this strain did not agglutinate with the K cholerae 0139 diagnostic antiserum (absorbed with CA385, and K cholerae 022 and 0155). It also agglutinated with antisera to K cholerae 022 and cross-reacting A . trota (strain 1354), but not with antiserum to K cholerae 0155. The strain was designated N-57.
The results of agglutination and agglutinin-absorption tests are shown in Table 1 . Cross-absorption of antisera to K cholerae 0139 and K mimicus with heterologous bacteria of K mimicus and K cholerae 0139 caused reductions in antibody titres to the homologous bacteria. Such reductions in homologous titres occurred when antisera to K cholerae 022 and A . trota were The SDS-PAGE separation profile of LPS from r mimicus N-57 and ?! cholerae 0139 AI-1852 is shown in Fig. 1 . The profile of Y mimicus resembled that of smooth bacteria revealing a core antigen (thick band at the bottom of the gel) and an 0-antigenic repeating polysaccharide (ladder-like portion in the top part of the gel). However, the LPS pattern of cholerae 0139 resembled that of semi-rough bacteria as reported earlier [l] revealing a modified core structure and no high mol. wt 0 antigen-specific side chain. Immunoblot studies with antisera to Y cholerae 0139 and ?! mimicus recognised homologous and heterologous LPS antigens equally well. In Fig. 2 , the immunoblots are shown with antiserum to ?! mimicus only. Compared with the LPS pattern in Fig. 1 , the core antigens in the bottom portion of the gel in Fig. 2 are not stained because the core antibody has been absorbed out. These studies further confirmed the antigenic relationship between ?! cholerue 0139 and ?! mimicus N-57.
The LD50 of the challenge strain of Y cholerae 0139, electrophoresed on an SDS-polyacrylamide 13.5% gel and were silver stained.
AI-1852, for infant mice was lo3 cfu in 0.1 ml of inoculum. A 1 in 10 dilution of polyclonal antiserum to isolate N-57 completely protected mice against a challenge dose of 100 LD50 of strain AI-1852. However, all the mice died when a 1 in 10 dilution of pre-immune rabbit serum was used. This suggested separated on an SDS-polyacrylamide 13.5% gel by electrophoresis, blotted on to a nitrocellulose membrane and probed with antiserum to K mimicus N-57.
that the shared antigenic epitope(s) between I? cholerae 0139 and Y mimicus N-57 is protective.
Some strains of I? mimicus produce a cholera toxin-like enterotoxin and a heat-stable enterotoxin [lo] . However, strain N-57 did not produce these toxins, and also gave a negative result for ctx in a PCR assay. This indicated that this strain may not produce watery diarrhoea.
Strain N-57 did not agglutinate with I? cholerae 0139-specific MAbs (ICL11 and ICL12) and also gave a negative result in the Bengal SMART test, which uses ICL12. It also gave a negative result in the PCR assay specific for l? cholerae 0139 as it failed to generate an amplicon of 416 bp [7] . These data suggest that such cross-reacting I? mimicus strains will not be misdiagnosed as Y cholerae 0139. The cross-reacting l? mimicus strain, N-57, could not be serogrouped with antisera to the 193 0 serogroups of I? cholerae. Therefore, a new serogroup, 0194, was assigned to this strain.
Structural analysis of surface polysaccharide of Y cholerae 0139 suggested that it contains two unique constituents, galactose cyclophosphate and colitose [ 1 11. Some cross-reacting bacteria share either or both of these structures [12, 131. A previous study found that the cross-reacting between l? mimicus strain N-1990 and I? cholerae 0139 is due to sharing of the galactosyl residue substituted with a cyclic phosphate by both bacteria [14] . The structural basis of crossreaction as well as the homology of the rfb genes encoding the surface polysaccharides in both Y cholerae 0139 and strain N-57 will need to be determined to further explore the relatedness between these two bacteria.
Worldwide efforts are being made to contain the threat of 'emerging and re-emerging pathogens'. I? cholerae 0139 is a newly emerged pathogen, and is considered to be the causative agent of the 'eighth' pandemic of cholera. The potential of cross-reacting bacteria for use as vaccine strains against 0139 cholera should also be explored.
